/ Thought Leadership
Empowering you through knowledge.
Browse our resources to feel more empowered about making informed decisions, whether you’re a patient, oncology care provider, or work in life sciences.
Articles
Today, Novartis announced the first results of a Phase III trial for a CDK4/6 inhibitor...
Endocrine therapy for early-stage HR+ breast cancer is witnessing significant advancements and moving away from...
Hormone positive breast cancer, also known as hormone receptor-positive (HR+) breast cancer, is a type...
As shocking as a breast cancer diagnosis is for the patient both physically and emotionally,...
“I never knew the density of my breasts could make such a difference in detecting...
Over 30% of breast cancer patients who undergo surgery or radiation therapy develop lymphedema, a...
Other Resources
Previous
Next
